CenturyLink Investment Management’s Edwards Lifesciences EW Stock Holding History

CenturyLink Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-6,231	Closed	-$250K	–	224
2016 Q3	$250K	Hold	6,231	–	–	0.08%	189
2016 Q2	$207K	Buy	+6,231	New	+$213K	0.07%	193
2015 Q4	–	Sell	-19,950	Closed	-$473K	–	278
2015 Q3	$473K	Sell	19,950 -552	-3%	-$13.3K	0.15%	168
2015 Q2	$487K	Sell	20,502 -420	-2%	-$9.48K	0.16%	171
2015 Q1	$497K	Buy	20,922 +5,784	+38%	+$130K	0.16%	175
2014 Q4	$321K	Buy	+15,138	New	+$304K	0.09%	201

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CenturyLink Investment Management's EW Position: Q4 2016 in Review

CenturyLink Investment Management sold out of Edwards Lifesciences (EW) in Q4 2016, closing a stake of 6,231 shares — an estimated $250K sold.

CenturyLink Investment Management first reported a position in EW in Q4 2014 and held it in 6 quarters. The position peaked at $497K in Q1 2015. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.

CenturyLink Investment Management reported no remaining Edwards Lifesciences position as of Q4 2016 after selling out during the quarter.
CenturyLink Investment Management sold 6,231 Edwards Lifesciences shares in Q4 2016, an estimated $250K.
CenturyLink Investment Management first reported a position in Edwards Lifesciences in Q4 2014 and held it in 6 quarters.
CenturyLink Investment Management's Edwards Lifesciences position peaked at $497K in Q1 2015.
686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.

Based on CenturyLink Investment Management's 13F filing for Q4 2016, filed 11 Jan 2017.